Brilliant Blue has been researched along with lysophosphatidylcholines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitani, H; Sato, M; Takenouchi, T | 1 |
1 other study(ies) available for Brilliant Blue and lysophosphatidylcholines
Article | Year |
---|---|
Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Benzenesulfonates; Calcium; Cell Cycle Proteins; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Microglia; Mitogen-Activated Protein Kinase 1; Purinergic P2 Receptor Antagonists; Receptors, G-Protein-Coupled; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |